Verano Holdings (VRNO) Net Margin (QoQ) (2021 - 2026)
Verano Holdings (VRNO) Net Margin (QoQ) (2021 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.34 Bn | 43.38 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.87 Bn | 40.22 Bn | 2.15 Bn |
| 3 | Zoetis | 32.46 Bn | 30.78 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.62 Bn | 22.82 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.97 Bn | 18.08 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.94 Bn | 11.41 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.15 Bn | 9.98 Bn | - |
| 10 | Verano Holdings | 445.39 Mn | 360.20 Mn | 99.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 241.00 |
| Mar 31, 2026 | 8,021.00 |
| Dec 31, 2025 | -6,716.00 |
| Sep 30, 2025 | -1,214.00 |
| Jun 30, 2025 | -398.00 |
| Mar 31, 2025 | 11,949.00 |
| Dec 31, 2024 | -10,533.00 |
| Sep 30, 2024 | -986.00 |
| Jun 30, 2024 | 55,485.00 |
| Mar 31, 2024 | -53,205.00 |
| Dec 31, 2023 | -2,519.00 |
| Sep 30, 2023 | -182.00 |
| Jun 30, 2023 | -151.00 |
| Mar 31, 2023 | 9,159.00 |
| Dec 31, 2022 | -7,676.00 |
| Sep 30, 2022 | -1,449.00 |
| Jun 30, 2022 | -2,708.00 |
| Mar 31, 2022 | 2,591.00 |
| Dec 31, 2021 | 256.00 |
| Sep 30, 2021 | 907.00 |